Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,947 public trials 2,015 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia

NCT04232241

Conditions
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Bone Marrow Diseases, +14 more
Locations
  • LKH-Univ. Klinikum Graz Graz, Austria
  • Medizinische Universität Innsbruck Innsbruck, Austria
  • Medizinische Universität Wien, Universitätsklinik für Innere Medizin I Einrichtung für Stammzelltransplantation KMT Vienna, Austria
  • Institute of Hematology and Blood Transfusion Prague, Czechia
View all 24 locations
View Trial Details
Active, Not Recruiting

A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell Lymphoma

NCT03952078

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Stanford University Palo Alto, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Washington University St Louis, Missouri, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma

NCT03934567

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
  • China-Japan Friendship Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
  • Jilin Cancer Hospital Changchun, China
View all 26 locations
View Trial Details
Active, Not Recruiting

A Clinical Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Abexinostat in Chinese Patients

NCT04024696

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
  • Zhejiang Cancer Hospital Hangzhou, China
  • Tianjin Medical University General Hospital Tianjin, China
  • The Affiliated Hospital of Xuzhou Medical University Xuzhou, China
View Trial Details

Related conditions